ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 193 filers reported holding ANIKA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 13.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $975,000 | +4.8% | 18,810 | +11.0% | 0.09% | +6.0% |
Q3 2019 | $930,000 | +35.0% | 16,950 | 0.0% | 0.08% | +37.7% |
Q2 2019 | $689,000 | +24.1% | 16,950 | -7.6% | 0.06% | +24.5% |
Q1 2019 | $555,000 | -10.8% | 18,350 | -0.8% | 0.05% | -19.7% |
Q4 2018 | $622,000 | -20.3% | 18,500 | 0.0% | 0.06% | -1.6% |
Q3 2018 | $780,000 | +31.8% | 18,500 | 0.0% | 0.06% | +24.0% |
Q2 2018 | $592,000 | -39.0% | 18,500 | -5.1% | 0.05% | -34.2% |
Q1 2018 | $970,000 | -10.9% | 19,500 | -3.5% | 0.08% | -6.2% |
Q4 2017 | $1,089,000 | -6.6% | 20,200 | +0.5% | 0.08% | -10.0% |
Q3 2017 | $1,166,000 | +67.5% | 20,100 | +42.6% | 0.09% | +60.7% |
Q2 2017 | $696,000 | +14.5% | 14,100 | +0.7% | 0.06% | +16.7% |
Q1 2017 | $608,000 | -11.9% | 14,000 | -0.7% | 0.05% | -9.4% |
Q4 2016 | $690,000 | -6.4% | 14,100 | -8.4% | 0.05% | +12.8% |
Q3 2016 | $737,000 | -20.3% | 15,400 | -10.7% | 0.05% | +17.5% |
Q2 2016 | $925,000 | -45.7% | 17,250 | -54.7% | 0.04% | -36.5% |
Q1 2016 | $1,703,000 | – | 38,090 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |